These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 37716342

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
    Zhang M, Liu X, Chen Z, Jiang S, Wang L, Tao M, Miao L.
    J Pharm Biomed Anal; 2022 Mar 20; 211():114562. PubMed ID: 35124453
    [Abstract] [Full Text] [Related]

  • 3. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
    Aghai F, Zimmermann S, Kurlbaum M, Jung P, Pelzer T, Klinker H, Isberner N, Scherf-Clavel O.
    Anal Bioanal Chem; 2021 Jan 20; 413(2):599-612. PubMed ID: 33155133
    [Abstract] [Full Text] [Related]

  • 4. Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring.
    Koller D, Vaitsekhovich V, Mba C, Steegmann JL, Zubiaur P, Abad-Santos F, Wojnicz A.
    Talanta; 2020 Feb 01; 208():120450. PubMed ID: 31816725
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Simultaneous determination of three tyrosine kinase inhibitors and three triazoles in human plasma by LC-MS/MS: applications to therapeutic drug monitoring and drug-drug interaction studies.
    Li N, Liu L, Liu D, Yu H, Yang G, Qiu L, Chen Y, Xiang D, Gong X.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Oct 01; 1246():124276. PubMed ID: 39208604
    [Abstract] [Full Text] [Related]

  • 7. A liquid chromatography-tandem mass spectrometry method for simultaneous quantification of thirty-nine tyrosine kinase inhibitors in human plasma.
    Guo ZX, Wu YE, Shi HY, van den Anker J, Liang P, Zheng Y, Zhao XW, Feng R, Zhao W.
    J Pharm Biomed Anal; 2023 Feb 05; 224():115159. PubMed ID: 36442459
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method.
    Posocco B, Zanchetta M, Orleni M, Gagno S, Montico M, Peruzzi E, Roncato R, Gerratana L, Corsetti S, Puglisi F, Toffoli G.
    Ther Drug Monit; 2024 Aug 01; 46(4):485-493. PubMed ID: 38366332
    [Abstract] [Full Text] [Related]

  • 9. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
    Abdel-Megied AM, Eldehna WM, Abdelrahman MA, Elbarbry FA.
    Molecules; 2020 Dec 06; 25(23):. PubMed ID: 33291270
    [Abstract] [Full Text] [Related]

  • 10. Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
    Decosterd LA, Mercier T, Ternon B, Cruchon S, Guignard N, Lahrichi S, Pesse B, Rochat B, Burger R, Lamoth F, Pagani JL, Eggimann P, Csajka C, Choong E, Buclin T, Widmer N, André P, Marchetti O.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov 10; 1157():122160. PubMed ID: 32891946
    [Abstract] [Full Text] [Related]

  • 11. Development and validation of an analytical method using liquid chromatography-tandem mass spectrometry for the therapeutic drug monitoring of seven cardiovascular drugs in clinical usage.
    Abady MM, Jeong JS, Kwon HJ.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan 01; 1214():123552. PubMed ID: 36469961
    [Abstract] [Full Text] [Related]

  • 12. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
    Johannsen JO, Reuter H, Hoffmann F, Blaich C, Wiesen MHJ, Streichert T, Müller C.
    J Pharm Biomed Anal; 2019 Feb 05; 164():373-381. PubMed ID: 30439665
    [Abstract] [Full Text] [Related]

  • 13. Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring.
    Llopis B, Robidou P, Tissot N, Pinna B, Gougis P, Aubart FC, Campedel L, Abbar B, Weil DR, Uzunov M, Gligorov J, Salem JE, Funck-Brentano C, Zahr N.
    J Pharm Biomed Anal; 2021 Apr 15; 197():113968. PubMed ID: 33618135
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous determination of dacomitinib and its major metabolite, O-desmethyl dacomitinib in human plasma by LC-MS/MS and its application to clinical testing in patients with non-small cell lung cancer.
    Feng X, Ding Y, Zhang P, Fu Q, Zhang L, Zheng H.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct 01; 1182():122940. PubMed ID: 34564058
    [Abstract] [Full Text] [Related]

  • 15. Development and validation of a multiplex HPLC-MS/MS assay for the monitoring of JAK inhibitors in patient plasma.
    Tachet J, Versace F, Mercier T, Buclin T, Decosterd LA, Choong E, Girardin FR.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Nov 15; 1230():123917. PubMed ID: 37956468
    [Abstract] [Full Text] [Related]

  • 16. Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoring.
    Aghai-Trommeschlaeger F, Zimmermann S, Gesierich A, Kalogirou C, Goebeler ME, Jung P, Pelzer T, Kurlbaum M, Klinker H, Isberner N, Scherf-Clavel O.
    Clin Biochem; 2022 Nov 15; 105-106():35-43. PubMed ID: 35483452
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous Determination of Imatinib, Dasatinib, and Nilotinib by Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Therapeutic Drug Monitoring.
    Wojnicz A, Colom-Fernández B, Steegmann JL, Muñoz-Calleja C, Abad-Santos F, Ruiz-Nuño A.
    Ther Drug Monit; 2017 Jun 15; 39(3):252-262. PubMed ID: 28490048
    [Abstract] [Full Text] [Related]

  • 18. Quantitation of 10 antibiotics in plasma: Sulfosalicylic acid combined with 2D-LC-MS/MS is a robust assay for beta-lactam therapeutic drug monitoring.
    Palayer M, Chaussenery-Lorentz O, Boubekeur L, Urbina T, Maury E, Maubert MA, Pilon A, Bourgogne E.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Apr 15; 1221():123685. PubMed ID: 37023569
    [Abstract] [Full Text] [Related]

  • 19. Development and validation of a novel LC-MS/MS method for simultaneous quantitative determination of tyrosine kinase inhibitors in human plasma.
    Lou Y, Qin H, Hu Q, Chai Y, Zhou H, Chen M, Wang Q, Huang P, Gu J, Zhang Y.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct 01; 1208():123394. PubMed ID: 35932695
    [Abstract] [Full Text] [Related]

  • 20. LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
    Kivrane A, Grinberga S, Sevostjanovs E, Igumnova V, Pole I, Viksna A, Bandere D, Krams A, Cirule A, Pugovics O, Ranka R.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov 15; 1185():122986. PubMed ID: 34688197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.